Multiclass HCV resistance to interferon-free direct acting antivirals regimens in real life failures advocates for tailored second-line therapies
Velia Chiara Di Maio(University of Rome Tor Vergata), Valeria Pace Palitti(Azienda USL di Pescara), Valeria Cento(Rostov State Medical University), Giovanni Battista Gaeta, Antonio Grieco(Università Cattolica del Sacro Cuore), C. D’Ambrosio, Gabriella d’Ettorre(Policlinico Umberto I), Roberto Gulminetti(University of Pavia), Bianca Bruzzone(Ospedale Policlinico San Martino), Vincenza Calvaruso(University of Palermo), Stefania Paolucci(Policlinico San Matteo Fondazione), M. Melis(University of Sassari), F. De Leonardis(University of Rome Tor Vergata), Simona Landonio(ASST Fatebenefratelli Sacco), M. Aragri(University of Rome Tor Vergata), A. Picciotto(Fondazione Bruno Kessler), V. Boccaccio(Humanitas University), Mario Starace(Vita-Salute San Raffaele University), C. Pasquazzi(Azienda Ospedaliera Sant'Andrea), Letizia Marinaro(University of Turin), Gabriella Verucchi(University of Bologna), S. Francioso, Ada Bertoli(IRCCS Policlinico San Donato), Ilaria Lenci, Ennio Polilli(Azienda USL di Pescara), Francesco Santopaolo(University of Rome Tor Vergata), Ivana Maida, Valeria Ghisetti(Ospedale Amedeo di Savoia), Giorgio Barbarini(Humanitas University), Alessandro Mancon(Luigi Sacco Hospital), Chiara Masetti(NHS Blood and Transplant), Teresa Pollicino(University of Messina), Dante Romagnoli(University of Modena and Reggio Emilia), F.P. Antonucci(University of Rome Tor Vergata), M.C. Sorbo(University of Rome Tor Vergata), Nicola Coppola(University of Campania "Luigi Vanvitelli"), Alessia Ciancio(Department of Medical Sciences), Laura Sticchi(Ospedale Policlinico San Martino), T. Ruggiero, Pietro Andreoné, Valeria Micheli(ASST Fatebenefratelli Sacco), Stefano Novati(Policlinico San Matteo Fondazione), Raffaele Cozzolongo, Manuela Merli(Policlinico Umberto I), Silvia Barbaliscia(University of Rome Tor Vergata), Jacopo Vecchiet(University of Chieti-Pescara), C. Magni(ASST Fatebenefratelli Sacco), Filomena Morisco, P. Cacciatore(Azienda USL di Pescara), Antonio Di Biagio
Cited by 1
Related Papers
Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease†
|Hepatology|2009|1.4k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
EASL Clinical Practice Guidelines on nutrition in chronic liver disease
|Journal of Hepatology|2018|1k
Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide
|Gastroenterology|2018|513